Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in Phase 3 Study of People with Severe Steroid-Dependent Asthma

Sanofi Contacts:

Media Relations

Investor Relations

Ashleigh Koss 

George Grofik

Tel: +1 908 981 8745

Tel. +33 (0)1 53 77 45 45

[email protected]

[email protected]

Regeneron Contacts:

Media Relations

Investor Relations

Arleen Goldenberg

Manisha Narasimhan, Ph.D.

Tel: +1 (914) 847-3456

Tel: 1 (914) 847-5126

Mobile: +1 (914) 260-8788

[email protected]

[email protected]